- Litigation Finance Insider
- Posts
- Why a £40m Barclays litigation case on dangerous breast implants could prove a gamechanger
Why a £40m Barclays litigation case on dangerous breast implants could prove a gamechanger
![](https://media.beehiiv.com/cdn-cgi/image/fit=scale-down,format=auto,onerror=redirect,quality=80/uploads/asset/file/d49e9010-b37f-48e4-9279-5de0d30db6e0/philippe-spitalier-MUr_fp74Ivo-unsplash-scaled.jpg?t=1680119842)
A £40m litigation case against Barclays could prove to be a gamechanger, opening the floodgates for creditors to pursue banks for questionable restructurings of companies which have since become insolvent and are unable to make creditors whole. Financed by funder Henderson & Jones, which purchased the claim from the liquidators of the Hospital Medical Group, the claim alleges that a restructure of the Group was illegally designed to defraud the Group’s creditors, including women who received illegally made and dangerous breast implants. Read more.